Serum cryptococcal antigen in patients with AIDS.
Feldmesser
M
M
Harris
C
C
Reichberg
S
S
Khan
S
S
Casadevall
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000150:complications*; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000946:Antigens, Fungal / Q000032:analysis* / Q000097:blood; D018791:CD4 Lymphocyte Count; D003453:Cryptococcosis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D003937:Diagnosis, Differential; D018450:Disease Progression; D004352:Drug Resistance, Microbial; D005189:False Positive Reactions; D015725:Fluconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007841:Latex Fixation Tests; D051379:Mice; D011134:Polysaccharides / Q000276:immunology
D000935:Antifungal Agents; D000946:Antigens, Fungal; D011134:Polysaccharides; D000666:Amphotericin B; D015725:Fluconazole